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The pKa of Brønsted acids controls their reactivity
with diazo compounds†
Na Fei, Basilius Sauter and Dennis Gillingham*
We study the O-alkylation of phosphate groups by alkyl diazo
compounds in a range of small molecules and biopolymers. We
show that the relatively high pKa of phosphate in comparison to
the other naturally occurring Brønsted acids can be exploited to
control alkylation selectivity. We provide a simple protocol for
chemical modification of some of the most important instances
of phosphates in natural compounds including in small molecule
metabolites, nucleic acids, and peptides.
The phosphate group and its esters are ubiquitous in Nature,
serving critical roles in nucleic acids, cell membranes, metabolism,
signal transduction, and numerous secondary metabolites.1,2
Protein phosphorylation is the most important post-translation
modification of proteins, and yet, despite more than sixty years
of study, most instances remain poorly understood.3 It is a
diﬃcult problem to study: signal transduction networks are
complicated and locating phosphorylation sites in proteins in time
and space is analytically challenging.4–7 Chemical methods
to build or modify phosphate esters have been essential in
studying their biology but the two main approaches have
limitations: phosphorus(III) chemistry is water-sensitive (although
recent efforts are addressing this issue)8 and phosphate ester
activation leads to side-reactions. For example, one challenge
in selective inositol phosphate syntheses9,10 is their proclivity
for phosphate ester migration once they are activated.11 Diazo
based esterification would offer a solution to such problems
since it operates by O-alkylation rather than acyl transfer. Diazo
esterification is used often in organic synthesis and has
recently been explored by the Raines lab as a labelling reaction
in chemical biology. They have developed techniques for the
mild aqueous generation of diazo compounds12 and shown
how these can be used for the reversible labelling of carboxylate
groups in proteins.13,14
We demonstrate here that pH control of the reaction medium
not only reduces acid-mediated hydrolysis of diazo compounds,
judged by diazo compound half-life, (see the ESI† page 5), but
also allows toggling of O-alkylation selectivity amongst Brønsted
acids (see Path B in Fig. 1).
Despite the importance of the phosphate esters and their known
reactivity with diazo compounds no head-to-head comparison of
their reactivity with that of carboxylates or a detailed look at the
reactivity diﬀerence between phosphate mono- and diesters has been
attempted. There are a handful of cases of phosphate ester alkylation
by diazo compounds.15–21 For example, nucleotide monophosphates
were first modified by phenyldiazomethane in 1955,22 and caged
inositol and nucleoside monophosphates are often made through
reactions of phosphates with diazo compounds.23,24 For example, a
diazo-substituted coumarin25 has been employed as a photocaging
reagent of DNA and RNA before delivery into zebrafish. While these
reports highlight the potential of phosphate alkylation, they did not
explore the reaction scope, mechanism, or compare of reactions with
different Brønsted acids. In our own work on metal-catalysed DNA
and RNA alkylation by diazo compounds,26–28 we sometimes found
low levels of phosphate alkylation in product streams. In this paper
we take a close look at phosphate monoester alkylation and compare
it to carboxylate and phosphate diester alkylation under neutral
pH aqueous conditions.
Fig. 1 Diazo stability in water is controlled by its pKa (Path A); Brønsted
acids capable of protonating diazo compounds lead toO-alkylation (Path B).
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For reactions of diazo compounds in water the pKa of its
protonated form (the diazonium ion) is critical.13 If the conjugate
base (1 in Fig. 1) is too basic it will be protonated quickly by water
and decompose unselectively through hydrolysis (Path A in
Fig. 1).29 When used to perform transformations in water diazo
compounds akin to diazomethane must therefore be used in
enormous excess since hydrolysis will always predominate (for
example diazomethane has a pKa of 10).
29 If too weakly basic
diazo compounds will not deprotonate the Brønsted acids
(required for Path B in Fig. 1) to initiate reaction – compounds
in this class include diazomalonates and donor–acceptor sub-
stituted diazo esters. These stable diazo compounds have long
lifetimes in water and hence can be used to perform aqueous
metal-carbene reactions. Their weak basicity, however, renders
them of little value in Brønsted acid alkylation. Quantifying the
middle ground between these two extremes is essential for
controlling selectivity in diazo-type esterifications.
The first step in a productive diazo-type O-alkylation is proto-
nation by the Brønsted acid (see Path B in Fig. 1).30 It should then
be possible to exploit pKa diﬀerences between acids to control
O-alkylation selectivity. To test this hypothesis we examined product
ratios of CMP versus benzoic acid alkylation in aqueous buﬀer at
diﬀerent pHs using commercially available trimethylsilyldiazo-
methane (1b in Fig. 2) as the diazo compound. Indeed at low pH
benzoic acid alkylation is preferred, but as the pH is raised phosphate
alkylation begins to dominate (see Fig. 2). This is consistent
with benzoic acid being largely benzoate at pHs higher than six,
while a large fraction of the phosphate remains protonated.
Although 1b was a convenient, highly basic, diazo compound for
preliminary hypothesis testing, its extreme reactivity (compara-
ble to diazomethane) would limit its practical application. The
ideal diazo compound would have pKb that matches the pKa of
the Brønsted acid. Unfortunately there has been no tabulation
of pKas for diazo compounds. Raines
13 selected the pKa of the
parent alkyl group as an expedient for diazo acidity in their
discussion of ester alkylation and found that diazo compounds
derived from fluorene or a-aryl amides delivered optimal alkylation
yields. The respective carbon acids of these have pKa values in the
mid-twenties. We elected to choose a diﬀerent series of structures
based on practical considerations (diazo compounds 1c, 1d,
and ethyl a-diazoacetate (not shown) were tested in a standard
reaction with CMP), but our results are qualitatively in agree-
ment with those of the Raines lab. In our case the most eﬀective
diazo compound was 1d, whose parent carbon acid has a pKa of
approximately 25 in water.31 The more basic compound 1c also
gave product, but it was prone to rapid degradation; the resonance
stabilized compound ethyl a-diazoacetate gave undetectable
levels of alkylation product.
The reaction is general. We selected a range of biologically
relevant monophosphates and looked at their reaction with
either diazo compounds 1c or 1d (see Table 1). The yields are
not high (21–74% depending on the substrate) but the approach’s
simplicity and conciseness should override the practical dis-
advantage of moderate yields. In general we consider 1d the
more valuable reagent because the ortho-nitrobenzyl (o-NO2-Bn)
adduct is photolabile, offering opportunities for photo-uncaging
applications (see the ESI† pages 15 & 41 for photo-uncaging
examples with compounds 6g and 14).32 1d has the additional
advantage that it is more stable than most alkyl diazo compounds
since the ortho-nitro group provides resonance stabilization of
the diazo anion.
Modifications of phosphates within large biopolymers would be
a valuable application of diazo alkylation. While this reaction has
previously been employed in the alkylation of nucleoside mono-
phosphates and nucleic acid oligomers, past work suﬀered from a
lack of selectivity, giving bothmono- and diester alkylation.16,18 The
exception is the work of the Friedman lab, who have shown that
terminal phosphates are strongly preferred over phosphate diesters
in oligonucleotide alkylation.20,21 We propose that pH buﬀering in
the vicinity of the Brønsted acid’s pKa is the decisive diﬀerence for
selectivity. This is supported by the poor reactivity of the phosphate
diesters shown in the bottom two entries of Table 1 where less
than 5% conversion is observed – identical conditions lead to
clean alkylation of phosphate monoesters. There are cases where
phosphate diester alkylation has been used in practice, but an
enormous excess is always employed.19,25 With 30 equivalents of
1d we begin to see phosphate diester alkylation (data not
shown), but under these forcing conditions substantial amounts
of sulfonate alkylation of the MES buffer salt were also observed
(see the ESI† page 9). The dramatic reactivity difference between
mono- and diesters augured well for a selective 50-phosphate
alkylation in larger oligonucleotides.
Oligonucleotides bearing terminal phosphates are alkylated
selectively (Fig. 3). A simple hexanucleotide (8, see trace a in
Fig. 3) bearing a 50-phosphate was treated with the diazo
compound 1d in varying amounts at pH 7 (see traces b–g).
Optimal conversion was observed at 20 equivalents of 1d with
further increases leading to little improvement. The reactions
Fig. 2 Competition experiments at varying pH support the role of pKa in
reactions of Brønsted acids with trimethylsilyl diazomethane.
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are clean with most by-products derived from side-reactions of
the diazo compound with itself or water (see trace j for control
sample where 8 is not added to reaction) and not with the
backbone or the bases of the oligonucleotide (see trace h for
control experiment of 1d’s reaction with dephosphorylated 8).
Protein phosphorylation is a widespread post-translational
modification that regulates numerous functions.33 The ability
to selectively modify phosphates in a native protein would be a
powerful tool for studying phosphorylation networks.34 Alkylation
to create products 6f and 6g in Table 1 already suggested that a
selective phosphate alkylation in a peptide or protein might be
feasible. Although whole proteins with a precisely defined phos-
phorylation state are diﬃcult to obtain, many phosphorylated
model peptides are commercially available. Phosphorylation of
Y527 in the C-terminal region of c-Src causes this domain to fold
over on its SH2 domain, holding the protein in an inactive state.35
A 13-mer phosphorylated peptide of the c-Src C-terminal domain
(residues 521–533, see 10 in Table 2 header) has therefore become
an important model peptide in studying Src signalling. If the
commercially available TFA salt of 10 is dissolved in unbuffered
water (final pH 4.3) and treated directly with diazo, alkylation of
glutamic acid 531 (E531) is the major product (see entry 2).
Consistent with the pKas controlling selectivity, performing the
same reaction in pH 7 MOPS buffer switches the alkylation
Table 1 Alkylations of diverse naturally occurring monophosphates
a Conditions: Diazo compound as a stock solution was added to a 50 mM
solution of the phosphate in 250 mM MES buﬀer. Reactions were
stopped when diazo compound was completely consumed as determined
by the disappearance of the orange colour.
Fig. 3 50-Phosphates in DNA are alkylated cleanly by diazo compound 1d.
Conditions: the appropriate amount of 1d stock solution was added to a
100 mM solution of the oligonucleotide and aliquots were analysed by
HPLC at 30 minutes.
Table 2 Selective phosphate alkylation in the C-terminal tail of proto-
oncogenic protein c-Src as examined by HPLC-MS analysis
Entry Substrate pHa
Equiv.
1d
Major
product % conv.b
Y527:
(E524 + E531)c
1 11 7 2 14 o5 n.a.
2 10 4.3 20 13 40 r1 : 9d
3 10 7 2 12 43 (35) 13 : 1
4 10 7 3 12 52 (42) 15 : 1
5 10 7 5 12 68 (44) 11 : 1
6 10 7 10 12 75 (47) 11 : 1
7 10 7 15 12 95 (40) 11 : 1
a Run in 5 mM MOPS buﬀer at pH 7, pH 4.3 experiment is run in
unbuﬀered water and the pH is measured after the reaction. b First
number is conversion of starting peptide; number in parenthesis refers
to amount of alkylated phosphate. c Ratios are determined by HPLC
integration. d A small side-product obscures phosphate alkylation hence
we can only report a lower limit (see the ESI, Fig. S9–S13 for details).
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preference to Y527 (cf. entries 2 & 3). Although there are three
carboxylates available for alkylation (C-terminus, E524 and
E531), phosphate alkylation is the major product along with a
small amount of carboxylate alkylation (13a & 13b, sites of
alkylation are determined by MS/MS sequencing, see the ESI†
for pages 39–41 for details). In addition, while 2 equivalents of
1d leads to 43% conversion of peptide 10, dephosphorylated
peptide 11 is not detectably alkylated under the same condi-
tions (see ESI† page 32). Entries 3–7 investigate the effect of
adding more diazo compound and the ideal seems to be 3
equivalents; further addition of 1d increases consumption of
peptide 10, but also leads to substantial amounts of double
alkylation with little change in the yield of 12 (see number in
parenthesis in the conversion column of Table 2). A second study
on a model 5-mer phosphorylated peptide is given in the ESI† on
pages 43–46 and supports the generality of the observations in
Table 2. The results in Table 2 again indicate how pH can be
exploited to control selectivity in Brønsted acid alkylation, even
in the presence of competing acids.
The accepted mechanism of O-alkylation by diazo com-
pounds predicts that the pH of the medium could be used to
steer O-alkylation preference among Brønsted acids. We have
validated this prediction and shown how this property can be used
to selectively target phosphates in amixture of other Brønsted acids
including carboxylic acids and sulfonic acids.
In its present form the method is most useful for creating
photo-caged variants of peptides, nucleic acids, and phosphate
bearing metabolites. An exciting future application, however,
would be in phosphoproteomics34,36 and we are currently
working to apply the method in this area.
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